(Q40346815)

19 September 2017

title

In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique (English)

1 reference

19 September 2017

1 reference

1 reference

Esimone CO

1

1 reference

19 September 2017

Grunwald T

2

1 reference

19 September 2017

Wildner O

3

1 reference

19 September 2017

Nchinda G

4

1 reference

19 September 2017

Tippler B

5

1 reference

19 September 2017

Proksch P

6

1 reference

19 September 2017

Uberla K

7

1 reference

19 September 2017

publication date

1 January 2005

1 reference

Journal of Applied Microbiology

19 September 2017

published in

1 reference

19 September 2017

volume

99

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

1346-1355

1 reference

Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Medicinal plants and phytomedicines. Linking plant biochemistry and physiology to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

The Trojan exosome hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Adenoviruses in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Novel antiviral agents: a medicinal plant perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Quantification of Atlantic salmon type-I interferon using an Mx1 promoter reporter gene assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Rapid detection of HSV with an enzyme-linked virus inducible system (ELVIS) employing a genetically modified cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Can ethnopharmacology contribute to the development of antiviral drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2005.02732.X

10.1111/J.1365-2672.2005.02732.X

21 January 2018

Identifiers

DOI

1 reference

release_5tan76jszfe3da6genuckhapiu

19 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5tan76jszfe3da6genuckhapiu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference